PRICE T ROWE ASSOCIATES INC /MD/
Position in OBIO — Orchestra BioMed Holdings, Inc.
CIK 80255
BALTIMORE, MD
Position in OBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$141,053
-$1,372,223 QoQ
Shares Held
32,689
-91.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 77 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,651,841 across 303 Biotechnology names. OBIO ranks #269 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in OBIO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,053 | 32,689 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $1,513,276 | 364,645 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,045,597 | 421,612 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,174,828 | 438,369 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,969,312 | 460,120 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,948,680 | 487,170 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,635,087 | 512,663 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,504,528 | 552,703 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,009,564 | 571,075 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,684,410 | 622,608 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $5,446,686 | 624,620 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,532,199 | 647,457 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,318,304 | 680,547 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,844,293 | 685,801 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 HSAQ | — | 724,565 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 HSAQ | — | 727,202 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 HSAQ | — | 794,078 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 HSAQ | — | 798,683 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 HSAQ | — | 807,765 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 HSAQ | — | 810,138 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 HSAQ | — | 850,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 HSAQ | — | 850,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 HSAQ | — | 850,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||